Olmeact Tablet 40 mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Korea Daiichi Sankyo Co., Ltd.
MFDS item code 201305057 · Approved 2013.02.15 · Insurance code 680900160
This product's status changed to Approval withdrawn on 2025.12.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension
Essential hypertension is a condition of increased blood pressure that occurs without a specific cause; this medication helps lower blood pressure, reducing the burden on blood vessels and the heart, and helps maintain health. It reduces the risk of complications and improves quality of life. Therefore, it is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, administered regardless of meals. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time every day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while carefully monitoring their condition. <Elderly> No dose adjustment is required when administering this drug to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg once daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients.
<Pediatric patients> Safety and efficacy have not been established in pediatric patients.
This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to this medication or its components should not take it, and it should not be used by pregnant or nursing women, patients on dialysis, those with severe liver dysfunction, or patients with bile duct obstruction. It contains lactose, so patients with lactose intolerance or certain inherited conditions should not take it. Especially in diabetic patients taking aliskiren, this medication should not be used in combination. Patients with low blood volume or sodium may experience hypotensive symptoms, so their conditions should be carefully monitored before taking it, and they should be observed closely afterward. Patients with decreased kidney function or those who have received a kidney transplant should have their kidney function and electrolyte status regularly checked with blood tests. Patients with renal artery stenosis should also be careful as prolonged use of this medication may worsen kidney function. This medication can increase potassium levels in the blood, so patients at risk of hyperkalemia should undergo regular blood tests. Patients with aortic stenosis, mitral stenosis, or obstructive cardiomyopathy should exercise caution when taking this medication. Low blood pressure may cause dizziness, so driving or operating dangerous machinery should be avoided. This medication may have somewhat reduced blood pressure-lowering effects in Black patients. While taking this medication, side effects such as dizziness, headache, palpitations, back pain, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, sinusitis, cough, abdominal pain, indigestion, gastritis, nausea, hypercholesterolemia, hyperlipidemia, hyperuricemia, arthralgia, arthritis, myalgia, hair loss, pruritus, diarrhea, and elevated blood pressure may occur, but most are mild and temporary. Severe side effects may include angioedema, liver function abnormalities, hyperkalemia, acute renal failure, elevated serum creatinine, urticaria, severe allergic reactions, severe swelling, asthma, facial swelling, elevated blood pressure, increased serum creatinine, peripheral edema, and headache (which may include serious neurological symptoms); if any unusual symptoms occur, consult a doctor immediately. If chronic diarrhea and weight loss persist, discontinue the medication and seek specialist care. When combined with other medications, interactions may occur with potassium-sparing diuretics, potassium supplements, lithium preparations, and non-steroidal anti-inflammatory drugs, so it is essential to inform your doctor or pharmacist. Pregnant women should not take this medication, and nursing mothers should discontinue breastfeeding or stop the medication, as side effects may appear in infants. Safety for pediatric use has not been established, so it is advisable not to use it in children. Elderly patients may have higher drug concentrations in their bodies, so dose adjustments and caution are required. In case of overdose, hypotension and palpitations may occur; if symptoms are severe, immediate medical attention is necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to keep the storage temperature between 1 degree and 25 degrees Celsius at room temperature.
White oval film-coated tablet
28 tablets (14 tablets/PTP X 2)/carton
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Korea Daiichi Sankyo Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.